XML 61 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Schedule of deferred tax assets and liabilities [Abstract]    
Net operating loss carry forwards $ 27,022,000 $ 23,936,000
Orphan drug and research and development credit carry forwards 8,149,000 8,315,000
Equity based compensation 264,000 1,331,000
Intangibles 817,000 1,051,000
Total 36,252,000 34,633,000
Valuation allowance (36,252,000) (34,633,000)
Net deferred tax assets